Sebastien Heritier

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications

Paediatric-onset autoimmune cytopenia: How can we reduce the long-term mortality?

Paediatric-onset autoimmune cytopenia: How can we reduce the long-term mortality?

Journal: British journal of haematology
Published: March 11, 2026

Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for Histiocytosis.

Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for Histiocytosis.

Journal: HemaSphere
Published: February 08, 2026

Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.

Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.

Journal: Blood cancer journal
Published: December 15, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Journal: Blood advances
Published: October 03, 2025

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patients.

Journal: Blood advances
Published: October 03, 2025

Rationalizing thrombophilia screening in children: Insights from a 2019 retrospective study at a tertiary care hospital.

Rationalizing thrombophilia screening in children: Insights from a 2019 retrospective study at a tertiary care hospital.

Journal: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
Published: September 08, 2025

ALKATI Drives Nuclear Anaplastic Lymphoma Kinase (ALK) Expression in Histiocytic Neoplasms Without ALK Fusions.

ALKATI Drives Nuclear Anaplastic Lymphoma Kinase (ALK) Expression in Histiocytic Neoplasms Without ALK Fusions.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: August 08, 2025

Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patients.

Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patients.

Journal: British journal of haematology
Published: July 28, 2025

Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: a propensity score-matched study.

Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: a propensity score-matched study.

Journal: Blood advances
Published: June 20, 2025

Sustained Remission Off-Therapy in a Case of Infantile ALK-Positive Multisystem Histiocytosis Treated With Crizotinib.

Sustained Remission Off-Therapy in a Case of Infantile ALK-Positive Multisystem Histiocytosis Treated With Crizotinib.

Journal: Pediatric blood & cancer
Published: June 06, 2025

Childhood isolated C3d-positive AIHA: favorable prognosis but rare relapse or associated immunodeficiency.

Childhood isolated C3d-positive AIHA: favorable prognosis but rare relapse or associated immunodeficiency.

Journal: Blood advances
Published: June 02, 2025

Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis.

Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis.

Journal: European journal of neurology
Published: February 13, 2025
Showing 1-12 of 73

Last Updated: 09/26/2026